These results indicated that ATAD2 had a better discriminatory test performance and high diagnostic accuracy in distinguishing patients with HCC from healthy controls, similar to GPC3 (Figures 3(a) and 3(b)). The gene discussed is GPC3; the disease is hepatocellular carcinoma.